Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reda

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Leukemia|July 31, 2009
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre studyA Cortelezzi, M C Pasquini, A Gardellini, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
The neuroleptics. 8. Clinical methodologyT A Ban, J M Bordeleau, H R Debray, et al.
Leukemia|January 13, 2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemiaG Reda, R Cassin, M Gentile, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Journal of Clinical Neurology (Seoul, Korea)|July 2, 2024
Efficacy of Cerebellar Transcranial Magnetic Stimulation in Treating Essential Tremor: A Randomized, Sham-Controlled TrialAhmad Farag Ibrahim El-Adawy, Mohamed Al-Bahay M G Reda, Ali Mahmoud Ahmed, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Leukemia|July 31, 2009
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre studyA Cortelezzi, M C Pasquini, A Gardellini, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
The neuroleptics. 8. Clinical methodologyT A Ban, J M Bordeleau, H R Debray, et al.
Leukemia|January 13, 2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemiaG Reda, R Cassin, M Gentile, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Journal of Clinical Neurology (Seoul, Korea)|July 2, 2024
Efficacy of Cerebellar Transcranial Magnetic Stimulation in Treating Essential Tremor: A Randomized, Sham-Controlled TrialAhmad Farag Ibrahim El-Adawy, Mohamed Al-Bahay M G Reda, Ali Mahmoud Ahmed, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Pageof 4